AJR ARRS PQI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlos, R. C.
Right arrow Articles by Francis, I. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlos, R. C.
Right arrow Articles by Francis, I. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2002; 179:87-92
© American Roentgen Ray Society


Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid as an Intrabiliary Contrast Agent: Preliminary Assessment

Ruth C. Carlos1, Hero K. Hussain1, Julie H. Song2 and Isaac R. Francis1

1 Department of Radiology, MRI Section, University of Michigan Medical Center, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0300.
2 Department of Diagnostic Imaging, Rhode Island Hospital—Brown University School of Medicine, 593 Eddy St., Providence RI 02912-9706.

OBJECTIVE. We assessed the added efficacy of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (gadolinium-EOB) in depicting biliary structures compared with T2-weighted MR cholangiopancreatography (T2-MRCP) and measured reviewer preference and willingness-to-pay for the added value of biliary contrast.

SUBJECTS AND METHODS. Ten patients prospectively underwent T2-MRCP and gadolinium-EOB—enhanced MR cholangiography (EOB-MRC). Three radiologists reviewed the unpaired, then the paired, examinations, rating biliary visualization using a 5-point scale. The common bile, right and left hepatic ducts, and second-order branches were evaluated. Improved biliary visualization using paired over unpaired tests indicated the added value of contrast media. Kappa values measured interobserver reliability. A regression model controlling for fixed effects due to reviewer and subject correlation quantified improvement in ratings attributable to paired review.

RESULTS. Average visualization ratings for unpaired review of EOB-MRC were the following: common bile duct, 3.3; right hepatic duct, 2.7; left hepatic duct, 2.5; second-order branches, 1.4. Average visualization ratings for unpaired review of T2-MCRP were the following: common bile duct, 3.4; right hepatic duct, 1.8; left hepatic duct, 2.2; second-order branches, 0.9. Ratings improved using paired tests over EOB-MRC and T2-MRCP for all structures (p < 0.001) except for T2-MRCP common bile duct ratings (p > 0.05). Agreement was moderate to good except for EOB-MRC common bile duct ratings. Paired review improved ratings ({chi}2 < 0.0001) over T2-MRCP alone by 1.05 and over EOB-MRC alone by 0.68. Despite significant improvement, reviewers preferred unpaired T2-MRCP (53%) over unpaired EOB-MRC (17%) or paired tests (30%). Reviewers were willing to pay $25 (median) for gadolinium-EOB.

CONCLUSION. Combining T2-MRCP and EOB-MRC significantly improved biliary visualization over each test alone. However, improvement was small, and the perceived added value of gadolinium-EOB was modest.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadioGraphicsHome page
N. K. Lee, S. Kim, J. W. Lee, S. H. Lee, D. H. Kang, G. H. Kim, and H. I. Seo
Biliary MR Imaging with Gd-EOB-DTPA and Its Clinical Applications
RadioGraphics, October 1, 2009; 29(6): 1707 - 1724.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
D. A. Bluemke, D. Sahani, M. Amendola, T. Balzer, J. Breuer, J. J. Brown, D. D. Casalino, P. L. Davis, I. R. Francis, G. Krinsky, et al.
Efficacy and Safety of MR Imaging with Liver-specific Contrast Agent: U.S. Multicenter Phase III Study
Radiology, October 1, 2005; 237(1): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
B. M. Yeh, R. S. Breiman, B. Taouli, A. Qayyum, J. P. Roberts, and F. V. Coakley
Biliary Tract Depiction in Living Potential Liver Donors: Comparison of Conventional MR, Mangafodipir Trisodium-enhanced Excretory MR, and Multi-Detector Row CT Cholangiography--Initial Experience
Radiology, March 1, 2004; 230(3): 645 - 651.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Roentgen Ray Society.